Training and Support for Hybrid Closed-Loop Therapy. (January 2022)

• Record Type: Journal Article
• Authors: Boughton, Charlotte K.; Hartnell, Sara; Allen, Janet M.; Fuchs, Julia; Hovorka, Roman
• Is Part Of: Journal of diabetes science and technology. Volume 16:Number 1(2022)
• Page Start: 218
• Page End: 223
• Publication Date: 2022-01
• Subjects: artificial pancreas -- hybrid closed-loop -- training -- type 1 diabetes; Diabetes -- Periodicals; Medical technology -- Periodicals; Diabetes Mellitus -- Periodicals; 616.462005
• DOI: 10.1177/1932296820955168
• Languages: English
• ISSNs: 1932-2968

Abstract

Hybrid closed-loop therapy is an emerging technology transforming the management of type 1 diabetes (T1D). Research studies demonstrate glycemic and quality of life benefits of hybrid closed-loop therapy for people with T1D. Translating these outcomes into standard clinical practice is critical for reimbursement and improving access to this technology. High-quality training is essential for achieving optimal outcomes with hybrid closed-loop therapy. Basic diabetes skills and tasks are as important, or even more important, with closed-loop therapy than with standard insulin therapy and need to be reiterated. Establishing expectations of hybrid closed-loop therapy clearly at the outset promotes long-term usage and optimal outcomes. We share key aspects of training and support for users of commercially available hybrid closed-loop systems and consider who may benefit from this technology.